Driving Innovation,
Delivering Value

Ryvu Therapeutics is a clinical-stage drug discovery and development company focused on novel oncology therapies that address emerging targets in oncology. Internally discovered pipeline candidates at Ryvu use diverse therapeutic mechanisms driven by emerging knowledge of cancer biology, including small molecules and antibody-drug conjugates directed at kinases, synthetic lethality, and immuno-oncology targets.

Corporate presentation

Press releases

Go to Newsroom

Reports

Go to Reports

Webinars & Presentations

More Webinars & Presentations

Financial information

Stock info

Key Stock Details

Number of shares                               23 120 148

Number of votes                                  27 170 148

Nominal value of share                      0,40 zł

Bloomberg stock code                       RVU: PW

GPW Ticker                                             RVU

GPW Index                                               sWIG80

Media Pack

Download company assets

  • zip file

    Company logo pack

    Download
  • zip file

    Management board

    Download
  • zip file

    Labs

    Download
  • zip file

    Ryvu building

    Download
  • zip file

    About Ryvu

    Download

Contact
for Investors & Media

At Ryvu Therapeutics, we are dedicated to maintaining transparent and open communication with our media partners and investors. If you have any questions or require further information, please don’t hesitate to contact us at [email protected].